Vistagen TherapeuticsVTGN
13F holders, Q1 2026 (March 31)At the end of Q1 2026, 56 institutions reported holding Vistagen Therapeutics Inc. (VTGN) in their 13F filings, up 1 from Q4 2025. 13 opened new positions and 13 sold out. The largest holders were Orbimed Advisors LLC ($1.7M), TCG Crossover Management, LLC ($1.5M) and Vanguard Capital Management LLC ($900K). 3 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio), Paul Tudor Jones (0.0% of Tudor Investment Corporation's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Vistagen Therapeutics Inc.
- CUSIP
- 92840H400
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 13 | $741K |
| Exits | 13 | $418K |
All 13F filers, Q4 2025 → Q1 2026: 2,338,750 shares bought and 1,199,047 shares sold, net +1,139,703 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 56 holders
| Orbimed Advisors LLC | 0.04% | No change | 3,060,000 | $1.7M |
| TCG Crossover Management, LLC | 0.04% | No change | 2,676,580 | $1.5M |
| Vanguard Capital Management LLC | 0.00% | — | 1,574,200 | $900K |
| ADAR1 Capital Management, LLC | 0.03% | Add +20.5% | 751,141 | $429K |
| Acadian Asset Management LLC | 0.00% | New | 589,663 | $336K |
| Ikarian Capital, LLC | 0.04% | No change | 519,077 | $297K |
| Two Sigma Investments, LP | 0.00% | Add +140.1% | 469,619 | $268K |
| Geode Capital Management, LLC | 0.00% | Add +28.5% | 453,391 | $259K |
| BlackRock, Inc. | 0.00% | Add +6.1% | 448,507 | $256K |
| Millennium Management | 0.00% | Add +118.4% | 430,404 | $246K |
| Luminus Management LLC | 0.14% | Add +13.2% | 396,053 | $226K |
| Renaissance Technologies | 0.00% | Add +81.2% | 291,300 | $166K |
| AdvisorShares Investments LLC | 0.03% | Add +10.8% | 277,110 | $158K |
| Jane Street Group, LLC | 0.00% | Reduce -48.3% | 272,811 | $156K |
| Vanguard Fiduciary Trust Co. | 0.00% | — | 217,700 | $125K |
| Verdad Advisers, LP | 0.12% | New | 184,938 | $106K |
| XTX Topco Ltd | 0.00% | New | 152,849 | $87K |
| Shay Capital LLC | 0.01% | New | 144,452 | $83K |
| Susquehanna International Group, LLP | 0.00% | Reduce -57.4% | 142,607 | $82K |
| Boothbay Fund Management, LLC | 0.00% | No change | 134,571 | $77K |
| State Street Corp. | 0.00% | No change | 121,114 | $69K |
| Tudor Investment Corporation | 0.00% | Add +39.4% | 106,172 | $61K |
| Diadema Partners LP | 0.02% | Add +5.4% | 105,428 | $60K |
| Stempoint Capital LP | 0.01% | No change | 616,749 | $58K |
| Simplex Trading, LLC | 0.00% | New | 89,649 | $51K |
| UBS Group AG | 0.00% | Add +51.4% | 78,736 | $45K |
| Northern Trust Corp. | 0.00% | No change | 72,655 | $42K |
| Prudential Financial Inc. | 0.00% | New | 53,100 | $30K |
| Gsa Capital Partners LLP | 0.00% | New | 49,842 | $28K |
| Persistent Asset Partners Ltd | 0.01% | No change | 26,612 | $15K |
| Schonfeld Strategic Advisors LLC | 0.00% | Add +22.3% | 26,589 | $15K |
| Kestra Advisory Services, LLC | 0.00% | Reduce -0.1% | 26,000 | $15K |
| HRT Financial LP | 0.00% | Reduce -32.5% | 25,370 | $14K |
| HighTower Advisors, LLC | 0.00% | No change | 20,628 | $12K |
| Group One Trading LLC | 0.00% | Reduce -81.3% | 19,875 | $11K |
| Truvestments Capital LLC | 0.00% | No change | 16,992 | $10K |
| Two Sigma Securities, LLC | 0.00% | New | 16,495 | $9K |
| StoneX Group Inc. | 0.00% | Add +13.8% | 15,198 | $9K |
| Raymond James Financial Inc. | 0.00% | New | 14,884 | $9K |
| Caption Management, LLC | 0.00% | Reduce -12.6% | 14,664 | $8K |
| Vanguard Global Advisers, LLC | 0.00% | — | 10,809 | $6K |
| Performa Ltd (US), LLC | 0.00% | Add +650.0% | 7,500 | $4K |
| Osaic Holdings, Inc. | 0.00% | Reduce -21.6% | 4,133 | $2K |
| Royal Bank of Canada | 0.00% | New | 2,127 | $1K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -81.6% | 1,572 | $898 |
| Annis Gardner Whiting Capital Advisors, LLC | 0.00% | New | 600 | $343 |
| Cwm, LLC | 0.00% | No change | 582 | $333 |
| MAI Capital Management | 0.00% | No change | 526 | $301 |
| SBI Securities Co., Ltd. | 0.00% | No change | 288 | $165 |
| Jones Financial Companies LLLP | 0.00% | No change | 114 | $65 |
| Fairman Group, LLC | 0.00% | No change | 29 | $17 |
| JPMorgan Chase & Co. | 0.00% | No change | 16 | $9 |
| Northwestern Mutual Wealth Management Co. | 0.00% | New | 16 | $9 |
| BNP Paribas Financial Markets | 0.00% | No change | 13 | $7 |
| Citigroup Inc. | 0.00% | New | 1 | $1 |
| Morgan Stanley | 0.00% | Reduce -100.0% | 1 | $1 |
"% of holder's portfolio" is VTGN's weight in each manager's 13F, not the share of Vistagen Therapeutics Inc. the manager owns.